Nchi: Uingereza
Lugha: Kiingereza
Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)
Morphine sulfate
Ethypharm UK Ltd
N02AA01
Morphine sulfate
10mg
Modified-release capsule
Oral
Schedule 2 (CD)
Valid as a prescribable product
BNF: 04070200; GTIN: 5027229000104
PACKAGE LEAFLET: INFORMATION FOR THE USER ZOMORPH CAPSULES (morphine sulfate, 10mg, 30mg, 60mg, 100mg, 200mg) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. – Please keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. – If you suffer from any side effects that get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. IN THIS LEAFLET: 1. What Zomorph capsules are and what they are used for 2. Before you take Zomorph capsules 3. How to take Zomorph capsules 4. Possible side effects 5. How to store Zomorph capsules 6. Further information 1. WHAT ZOMORPH CAPSULES ARE AND WHAT THEY ARE USED FOR Zomorph capsules belong to a group of medicines called opioid analgesics. They contain the active ingredient morphine sulfate in a special slow-release form which gives relief from severe pain, particularly pain associated with cancer. 2. BEFORE YOU TAKE ZOMORPH CAPSULES DO NOT TAKE ZOMORPH CAPSULES IF: you have an allergy (hypersensitivity) to morphine sulfate or any of the other ingredients in the product _(see Section 6 and end of Section 2)_ you have breathing difficulties you have unexplained abdominal pains you have liver problems you have raised intracranial pressure (severe headache), for example from a head injury you have convulsions (fits) you have recently consumed a large amount of alcohol, or have been intoxicated paralytic ileus (bowel obstruction) you have ever taken monoamine oxidase inhibitors (MAOIs) for depression, or have done so in the last 14 days the patient is a child. TAKE SPECIAL CARE WITH ZOMORPH CAPSULES The dose should be reduced or stopped if you: are elderly are in a state of shock have liver or kidney problems have an underactive thyroid or adrenal gland have a Soma hati kamili
OBJECT 1 ZOMORPH CAPSULES Summary of Product Characteristics Updated 14-Oct-2016 | Ethypharm UK Ltd 1. Name of the medicinal product ZOMORPH capsules 10mg, 30mg, 60mg, 100mg, 200mg 2. Qualitative and quantitative composition • Morphine sulphate BP 10mg • Morphine sulphate BP 30mg • Morphine sulphate BP 60mg • Morphine sulphate BP 100mg • Morphine sulphate BP 200mg 3. Pharmaceutical form Sustained-release capsules. 4. Clinical particulars 4.1 Therapeutic indications Severe chronic pain and/or pain resistant to other analgesics, in particular pain associated with cancer. 4.2 Posology and method of administration Route of administration : orally. As directed by a medical practitioner. Recommended dosage Adults: Recommended dosage is one capsule twice daily, at 12-hourly intervals. Elderly: As with all narcotics, a reduction in dosage may be advisable in the elderly, as appropriate. Children: Not recommended. The capsules should not be chewed and should normally be swallowed whole. The dosage varies according to the severity of pain and the previous analgesic treatments received by the patient. If the pain persists, or if the patient develops tolerance to morphine, the dosage may be increased by prescribing the 10mg, 30mg, 60mg, 100mg and 200mg capsules in various combinations or alone to obtain the desired relief. Patients previously treated with immediate-release oral morphine should receive the same daily dose of sustained-release capsules, but in two divided doses at 12-hourly intervals. Patients previously treated with parenteral morphine should be given a sufficiently increased dosage to compensate for any reduction of the analgesic effect associated with oral administration. The dosage should be adjusted to meet the individual requirements of each patient. For patients who cannot swallow the capsules, their contents can be administered directly in semi-solid food (puree, jam, yoghurt) or via gastric or gastrostomy tubes of a diameter of more than 16 F.G. with an open distal end or lateral pores. It i Soma hati kamili